These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17633776)

  • 1. FDA notifications. FDA issues final guidance on human cell, tissue donations.
    AIDS Alert; 2007 Jun; 22(6):67-8. PubMed ID: 17633776
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA final guidance on software validation.
    Donawa M
    Med Device Technol; 2002 Apr; 13(3):20-4. PubMed ID: 12030100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA issues final guidance on nucleic acid tests.
    AIDS Alert; 2005 Apr; 20(4):46-7. PubMed ID: 15844224
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA notifications. Changes to ART guidelines detailed by the FDA.
    AIDS Alert; 2008 Mar; 23(3):33-4. PubMed ID: 18663777
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA issues guidance about HIV vaccine study.
    AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16791952
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA issues new security guidance: Operation Liberty Shield.
    Public Health Rep; 2003; 118(3):276. PubMed ID: 12820633
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA issues pharmacogenomics data submission guidance.
    Expert Rev Mol Diagn; 2005 May; 5(3):275-7. PubMed ID: 15934806
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA issues guidance on race and ethnicity data.
    Meadows M
    FDA Consum; 2003; 37(3):36. PubMed ID: 12793392
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA notifications. FDA's final guidance on HIV resistance testing.
    AIDS Alert; 2008 Jan; 23(1):10-1. PubMed ID: 18574867
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA notifications. OSHA: use rapid HIV test after HCW exposure.
    AIDS Alert; 2007 Apr; 22(4):45-7. PubMed ID: 17598193
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.
    Bottomley A; Jones D; Claassens L
    Eur J Cancer; 2009 Feb; 45(3):347-53. PubMed ID: 19013787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Path of least resistance. New drug development guidance needed from FDA.
    Huff B
    GMHC Treat Issues; 2006; 20(4-7):12. PubMed ID: 17228451
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementing the U.S. FDA guidance on pharmacogenomic data submissions.
    Goodsaid F; Frueh FW
    Environ Mol Mutagen; 2007 Jun; 48(5):354-8. PubMed ID: 17567848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA issues new rule on tissue safety.
    OR Manager; 2005 Jan; 21(1):5. PubMed ID: 15707142
    [No Abstract]   [Full Text] [Related]  

  • 15. New FDA guidance documents.
    Bradshaw ST
    Food Drug Law J; 2007; 62(2):429-31. PubMed ID: 17632971
    [No Abstract]   [Full Text] [Related]  

  • 16. New FDA xenotransplantation documents: a proposed rule and a draft guidance.
    Bloom ET
    Xenotransplantation; 2001 Aug; 8(3):153-4. PubMed ID: 11472622
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA transgenic animal guidance finally surfaces.
    Fox JL
    Nat Biotechnol; 2008 Nov; 26(11):1205-7. PubMed ID: 18997745
    [No Abstract]   [Full Text] [Related]  

  • 18. International Conference on Harmonisation; guidance on the M4 Common Technical Document--Quality: Questions and Answers/Location Issues; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Jun; 69(111):32358-9. PubMed ID: 15188781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cells, tissues, and cellular and tissue-based products; donor screening and testing, and related labeling. Interim final rule; opportunity for public comment.
    Food and Drug Administration, HHS
    Fed Regist; 2005 May; 70(100):29949-52. PubMed ID: 15915582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Conference on Harmonisation; Guidance on S8 Immunotoxicity Studies for Human Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Apr; 71(71):19193-4. PubMed ID: 16612859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.